Even if Neuren had the NA rights for other indications, it hard to imagine they could do better commercially than the agreement with Acadia.
- Forums
- ASX - By Stock
- NEU
- Ann: Investor Presentation, 14 March 2023
Ann: Investor Presentation, 14 March 2023, page-14
-
- There are more pages in this discussion • 132 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.50 |
Change
-0.020(0.10%) |
Mkt cap ! $2.606B |
Open | High | Low | Value | Volume |
$20.60 | $20.77 | $20.36 | $2.811M | 136.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 322 | $20.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.50 | 1314 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 117 | 20.400 |
5 | 164 | 20.390 |
4 | 223 | 20.380 |
4 | 490 | 20.370 |
6 | 491 | 20.360 |
Price($) | Vol. | No. |
---|---|---|
20.410 | 386 | 8 |
20.420 | 404 | 5 |
20.430 | 386 | 7 |
20.440 | 769 | 8 |
20.450 | 1383 | 7 |
Last trade - 14.56pm 15/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online